Evogene Ltd. current report, Q2 FY2021

Business Context and Reporting Period

Company: Evogene Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2021
Filing Date: August 31, 2021

This filing furnishes unaudited consolidated financial statements and Management's Discussion and Analysis (MD&A) for the six-month period ended June 30, 2021. The documents are incorporated by reference into the company's registration statements on Form F-3 and Form S-8.

Key Financial Metrics

The provided text serves as a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached exhibits (Exhibit 99.1 and 99.2) which are not included in the input text.

  • Revenue: Not provided in text.
  • Profit/Loss: Not provided in text.
  • Cash Flow: Not provided in text.
  • Debt and Liquidity: Not provided in text.

Material Changes

The filing text does not provide specific details regarding material changes in financial condition or results of operations compared to the prior comparable period. Such analysis is contained within the MD&A (Exhibit 99.2) referenced in this filing.

Guidance, Outlook, and Risks

The text does not contain specific management commentary, forward-looking guidance, risk factors, or descriptions of unusual items. These disclosures are expected to be found in the Management's Discussion and Analysis document (Exhibit 99.2) attached to this Form 6-K.

Investor Verification Checklist

  • Review Exhibit 99.1 for the specific unaudited consolidated financial statements (Balance Sheet, Income Statement, Cash Flow) for the six months ended June 30, 2021.
  • Review Exhibit 99.2 for the Management's Discussion and Analysis to understand the reasons behind financial performance and any material changes.
  • Verify the incorporation of these exhibits into the active registration statements (Form F-3 File No. 333-253300 and Form S-8 File Nos. 333-193788, 333-201443, and 333-203856).
  • Confirm the interactive data files (Exhibit 101) for detailed breakdowns of financial position and changes in equity.